Arrest time
0:00
Outcome
Freeze timers and lock counters. Use Reset between patients.
Epinephrine 1 mg IV
Not given
Doses given: 0 · q3–5 min
Defibrillations
0
200 J biphasic (or per device)
Reversible causes — Hs & Ts
Management
Universal cycle (every 2 minutes)
- : rate 100–120/min · depth 5–6 cm · full recoil · minimize interruptions (<10 s)
- : 30:2 (no advanced airway) → continuous compressions + 1 breath q6 s (10/min) once intubated
- 2 min at every rhythm check; pulse check ONLY if organized rhythm appears
- : EtCO₂ goal >10 mmHg (>20 mmHg better); abrupt rise → suspect ROSC
Rhythm check decision (q2 min)
- (VF / pulseless VT) → SHOCKABLE arm below
- (PEA / asystole) → NON-SHOCKABLE arm below
Shockable arm — VF / pulseless VT
- Tap to view annotated rhythm: ·
- After 2nd shock: 1 mg IV/IO q3–5 min · place advanced airway when feasible
- After 3rd shock: 300 mg IV/IO bolus (repeat 150 mg) OR 1–1.5 mg/kg
- Torsades / suspected hypoMg: 1–2 g IV over 5–20 min
Non-shockable arm — PEA / asystole
- 2 leads · confirm asystole vs fine VF (check gain, leads); if any doubt, treat as shockable
- 1 mg IV/IO ASAP, then q3–5 min
- 2 min · IV/IO · advanced airway + waveform capnography
- 2 min → if becomes shockable, switch to shockable arm and defibrillate immediately
Bradycardia (unstable, with pulse)
- 1 mg IV q3–5 min (max 3 mg)
- 5–20 mcg/kg/min or 2–10 mcg/min infusion
Tachycardia (unstable, with pulse)
- : narrow regular 50–100 J · narrow irregular 120–200 J · wide regular 100 J
- Stable wide-complex: 150 mg IV over 10 min or procainamide
- Stable narrow SVT: vagal → 6 mg IV, then 12 mg
Post-ROSC priorities
- SBP ≥ 90 (/ gtt prn)
- 32–36 °C
Code blue drugs — tap for dosing
Educational aid only — verify all doses against local protocols.